Editorial: infliximab de-escalation in inflammatory bowel disease using a therapeutic drug monitoring strategy – early promise but more data needed. Authors’ reply.

Editorial: infliximab de-escalation in inflammatory bowel disease using a therapeutic drug monitoring strategy – early promise but more data needed. Authors’ reply.

Aliment Pharmacol Ther. 2019 Mar;49(6):817-818

Authors: Bouguen G, Siproudhis L

PMID: 30811643 [PubMed – in process]

PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/30811643?dopt=Abstract